A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
Ko, A H, Tempero, M A, Shan, Y-S, Su, W-C, Lin, Y-L, Dito, E, Ong, A, Wang, Y-W, Yeh, C G, Chen, L-T
Published in British journal of cancer (20.08.2013)
Published in British journal of cancer (20.08.2013)
Get full text
Journal Article
Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells
Chu, P-C, Yang, M-C, Kulp, S K, Salunke, S B, Himmel, L E, Fang, C-S, Jadhav, A M, Shan, Y-S, Lee, C-T, Lai, M-D, Shirley, L A, Bekaii-Saab, T, Chen, C-S
Published in Oncogene (28.07.2016)
Published in Oncogene (28.07.2016)
Get full text
Journal Article
TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1
Huang, P-H, Lu, P-J, Ding, L-Y, Chu, P-C, Hsu, W-Y, Chen, C-S, Tsao, C-C, Chen, B-H, Lee, C-T, Shan, Y-S, Chen, C-S
Published in Oncogene (20.04.2017)
Published in Oncogene (20.04.2017)
Get full text
Journal Article
RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells
Lin, F-C, Liu, Y-P, Lai, C-H, Shan, Y-S, Cheng, H-C, Hsu, P-I, Lee, C-H, Lee, Y-C, Wang, H-Y, Wang, C-H, Cheng, J Q, Hsiao, M, Lu, P-J
Published in Oncogene (27.09.2012)
Published in Oncogene (27.09.2012)
Get full text
Journal Article
The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan
Su, Y.-Y., Chiang, N.-J., Chang, J.S., Wang, Y.-W., Shen, B.-N., Li, Y.-J., Hwang, D.-Y., Shan, Y.-S., Chen, L.-T.
Published in ESMO open (01.02.2023)
Published in ESMO open (01.02.2023)
Get full text
Journal Article
Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study
Chiang, N.-J., Tsai, K.K., Chen, J.-S., Yang, S.-H., Hsiao, H.-H., Shan, Y.-S., Chen, L.-T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
Chiang, N.-J., Chen, L.-T., Chen, J.-S., Yang, S.-H., Hsu, C., Shan, Y.-S., Yen, C.-J., Chen, M.-H., Tsou, H.-H.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study
Chang, H.-J., Chiu, Y.-F., Chen, J.-S., Li, C.-P., Ho, C.-L., Shyr, Y.-M., Chiou, W.-C., Yeh, C.-N., Hsieh, R.-K., Lin, Y.-L., Tien, Y.-W., Hwang, T.-L., Shan, Y.-S., Chen, L.-T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Significance of intraoperative peritoneal culture of fungus in perforated peptic ulcer
Shan, Y.-S., Hsu, H.-P., Hsieh, Y.-H., Sy, E. D., Lee, J.-C., Lin, P.-W.
Published in British journal of surgery (01.10.2003)
Published in British journal of surgery (01.10.2003)
Get full text
Journal Article
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
Chen, J.S., Hsu, C., Chiang, N.J., Tsai, C.S., Tsou, H.H., Huang, S.F., Bai, L.Y., Chang, I.C., Shiah, H.S., Ho, C.L., Yen, C.J., Lee, K.D., Chiu, C.F., Rau, K.M., Yu, M.S., Yang, Y., Hsieh, R.K., Chang, J.Y., Shan, Y.S., Chao, Y., Chen, L.T., Shen, Wen-Chi, Hsu, Hung-Chih, Hsu, Chih-Hung, Shen, Ying-Chun, Wang, Tsang-En, Li, Chung-Pin, Chen, Ming-Huang, Kao, Wei-Yao, Chang, Ping-Ying, Wu, Cheng-Chung, Teng, Chien-Lin, Lu, Chang-Hsien, Lin, Shyh-Jer, Wang, Being-Whey, Chen, Yen-Yang, Chin, Yung-Hsin, Chung, Tsai-Rong, Yu, Wei-Lan, Lee, Mei-Hua, Lin, Ling-Fang, Lin, Pei-Chyi, Wu, Ya-Ling, Wang, Hui-Ling, Lu, Li-Ju, Chen, Shiang-Yi, Wu, Chih-Chu, Wei, Te-Chih
Published in Annals of oncology (01.05.2015)
Published in Annals of oncology (01.05.2015)
Get full text
Journal Article
Clinical Factors Associated with Sodium Removal in Peritoneal Dialysis Patients
Shan, YS, Ding, XQ, Ji, J, Lv, WL, Cao, XS, Zhong, YH
Published in Journal of international medical research (01.10.2011)
Published in Journal of international medical research (01.10.2011)
Get full text
Journal Article
Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: a phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy
Blanc, J.F., Hubner, R., Li, C-P, Wang-Gillam, A., Bodoky, G., Dean, A., Shan, Y-S, Jameson, G., Macarulla Mercade, T., Lee, K-H, Cunningham, D., Chiu, C-F, Schwartsmann, G., Braiteh, F., von Hoff, D., Chen, L-T, Mamlouk, K., de Jong, F., Siveke, J.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
Effects of recombinant activated coagulation factor VII on apoptosis and expressions of Bcl-2 and Bax in rats with intracerebral hemorrhage
Ma, Y-M, Zheng, J-X, Xu, X, Shan, Y-S, Gao, Z-W, Chen, W-G
Published in European review for medical and pharmacological sciences (01.08.2018)
Get more information
Published in European review for medical and pharmacological sciences (01.08.2018)
Journal Article
Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
Chen, L.-T., Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G.S., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J.-F., Hubner, R., Chiu, C.-F., Schwartsmann, G., Braiteh, F., Belanger, B., Bayever, E., de Jong, F., von Hoff, D.D., Siveke, J.T.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Time course of selected treatment emergent adverse events (TEAEs) in NAPOLI-1: A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
Hubner, R.A., Chen, L.-T., Siveke, J.T., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G.S., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J.-F., Chiu, C.-F., Schwartsmann, G., Braiteh, F., Mamlouk, K., Belanger, B., de Jong, F., von Hoff, D.D., Wang-Gillam, A.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer
Cheng, Hui-Chuan, Liu, Yu-Peng, Shan, Yan-Shen, Huang, Chi-Ying, Lin, Forn-Chia, Lin, Li-Ching, Lee, Ling, Tsai, Chen-Hsun, Hsiao, Michael, Lu, Pei-Jung
Published in Carcinogenesis (New York) (01.11.2013)
Published in Carcinogenesis (New York) (01.11.2013)
Get full text
Journal Article
Meckel's diverticulum associated with ileal volvulus in a neonate
SY, E. D, SHAN, Y. S, TSAI, H. M, LIN, C. H
Published in Pediatric surgery international (01.09.2002)
Published in Pediatric surgery international (01.09.2002)
Get full text
Journal Article